Literature DB >> 22496370

Paired helical filaments from Alzheimer disease brain induce intracellular accumulation of Tau protein in aggresomes.

Ismael Santa-Maria1, Merina Varghese, Hanna Ksiezak-Reding, Anastasiya Dzhun, Jun Wang, Giulio M Pasinetti.   

Abstract

Abnormal folding of tau protein leads to the generation of paired helical filaments (PHFs) and neurofibrillary tangles, a key neuropathological feature in Alzheimer disease and tauopathies. A specific anatomical pattern of pathological changes developing in the brain suggests that once tau pathology is initiated it propagates between neighboring neuronal cells, possibly spreading along the axonal network. We studied whether PHFs released from degenerating neurons could be taken up by surrounding cells and promote spreading of tau pathology. Neuronal and non-neuronal cells overexpressing green fluorescent protein-tagged tau (GFP-Tau) were treated with isolated fractions of human Alzheimer disease-derived PHFs for 24 h. We found that cells internalized PHFs through an endocytic mechanism and developed intracellular GFP-Tau aggregates with attributes of aggresomes. This was particularly evident by the perinuclear localization of aggregates and redistribution of the vimentin intermediate filament network and retrograde motor protein dynein. Furthermore, the content of Sarkosyl-insoluble tau, a measure of abnormal tau aggregation, increased 3-fold in PHF-treated cells. An exosome-related mechanism did not appear to be involved in the release of GFP-Tau from untreated cells. The evidence that cells can internalize PHFs, leading to formation of aggresome-like bodies, opens new therapeutic avenues to prevent propagation and spreading of tau pathology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22496370      PMCID: PMC3370237          DOI: 10.1074/jbc.M111.323279

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  67 in total

1.  Structural analysis of Pick's disease-derived and in vitro-assembled tau filaments.

Authors:  M E King; N Ghoshal; J S Wall; L I Binder; H Ksiezak-Reding
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

2.  Proteasomal degradation of tau protein.

Authors:  Della C David; Robert Layfield; Louise Serpell; Yolanda Narain; Michel Goedert; Maria Grazia Spillantini
Journal:  J Neurochem       Date:  2002-10       Impact factor: 5.372

Review 3.  Pathways of unconventional protein secretion.

Authors:  Walter Nickel
Journal:  Curr Opin Biotechnol       Date:  2010-07-14       Impact factor: 9.740

4.  Exosomes are released by cultured cortical neurones.

Authors:  J Fauré; G Lachenal; M Court; J Hirrlinger; C Chatellard-Causse; B Blot; J Grange; G Schoehn; Y Goldberg; V Boyer; F Kirchhoff; G Raposo; J Garin; R Sadoul
Journal:  Mol Cell Neurosci       Date:  2006-01-30       Impact factor: 4.314

5.  Alzheimer's disease affects limbic nuclei of the thalamus.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

6.  Assembly-dependent endocytosis and clearance of extracellular alpha-synuclein.

Authors:  He-Jin Lee; Ji-Eun Suk; Eun-Jin Bae; Jung-Ho Lee; Seung R Paik; Seung-Jae Lee
Journal:  Int J Biochem Cell Biol       Date:  2008-01-20       Impact factor: 5.085

7.  Neuroprotective effects of grape seed extract on neuronal injury by inhibiting DNA damage in the gerbil hippocampus after transient forebrain ischemia.

Authors:  In Koo Hwang; Ki-Yeon Yoo; Duk Soo Kim; Youn-Kab Jeong; Jong Dai Kim; Hyun-Kyung Shin; Soon Sung Lim; Ick-Dong Yoo; Tae-Cheon Kang; Dong-Woo Kim; Won-Kuk Moon; Moo Ho Won
Journal:  Life Sci       Date:  2004-09-03       Impact factor: 5.037

Review 8.  Tau-directed drug discovery for Alzheimer's disease and related tauopathies: a focus on tau assembly inhibitors.

Authors:  Kurt R Brunden; Carlo Ballatore; Alex Crowe; Amos B Smith; Virginia M-Y Lee; John Q Trojanowski
Journal:  Exp Neurol       Date:  2009-09-08       Impact factor: 5.330

Review 9.  Role of tau protein in both physiological and pathological conditions.

Authors:  Jesus Avila; Jose J Lucas; Mar Perez; Felix Hernandez
Journal:  Physiol Rev       Date:  2004-04       Impact factor: 37.312

10.  Trans-synaptic spread of tau pathology in vivo.

Authors:  Li Liu; Valerie Drouet; Jessica W Wu; Menno P Witter; Scott A Small; Catherine Clelland; Karen Duff
Journal:  PLoS One       Date:  2012-02-01       Impact factor: 3.240

View more
  53 in total

Review 1.  Multimodality Review of Amyloid-related Diseases of the Central Nervous System.

Authors:  Michelle M Miller-Thomas; Adam L Sipe; Tammie L S Benzinger; Jonathan McConathy; Sarah Connolly; Katherine E Schwetye
Journal:  Radiographics       Date:  2016 Jul-Aug       Impact factor: 5.333

2.  Two novel Tau antibodies targeting the 396/404 region are primarily taken up by neurons and reduce Tau protein pathology.

Authors:  Jiaping Gu; Erin E Congdon; Einar M Sigurdsson
Journal:  J Biol Chem       Date:  2013-10-02       Impact factor: 5.157

3.  Sequence-dependent internalization of aggregating peptides.

Authors:  José R Couceiro; Rodrigo Gallardo; Frederik De Smet; Greet De Baets; Pieter Baatsen; Wim Annaert; Kenny Roose; Xavier Saelens; Joost Schymkowitz; Frederic Rousseau
Journal:  J Biol Chem       Date:  2014-11-12       Impact factor: 5.157

Review 4.  Tau Protein Squired by Molecular Chaperones During Alzheimer's Disease.

Authors:  Nalini Vijay Gorantla; Subashchandrabose Chinnathambi
Journal:  J Mol Neurosci       Date:  2018-09-28       Impact factor: 3.444

5.  Internalization of tau antibody and pathological tau protein detected with a flow cytometry multiplexing approach.

Authors:  Dov B Shamir; Nina Rosenqvist; Suhail Rasool; Jan T Pedersen; Einar M Sigurdsson
Journal:  Alzheimers Dement       Date:  2016-03-23       Impact factor: 21.566

Review 6.  Spreading of Pathology in Alzheimer's Disease.

Authors:  Zhong-Yue Lv; Chen-Chen Tan; Jin-Tai Yu; Lan Tan
Journal:  Neurotox Res       Date:  2017-06-16       Impact factor: 3.911

Review 7.  Prion-like properties of Tau protein: the importance of extracellular Tau as a therapeutic target.

Authors:  Brandon B Holmes; Marc I Diamond
Journal:  J Biol Chem       Date:  2014-05-23       Impact factor: 5.157

Review 8.  The complexity of tau in Alzheimer's disease.

Authors:  Nima N Naseri; Hong Wang; Jennifer Guo; Manu Sharma; Wenjie Luo
Journal:  Neurosci Lett       Date:  2019-04-25       Impact factor: 3.046

Review 9.  Extracellular vesicles in neurodegenerative disease - pathogenesis to biomarkers.

Authors:  Alexander G Thompson; Elizabeth Gray; Sabrina M Heman-Ackah; Imre Mäger; Kevin Talbot; Samir El Andaloussi; Matthew J Wood; Martin R Turner
Journal:  Nat Rev Neurol       Date:  2016-05-13       Impact factor: 42.937

Review 10.  Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer's disease.

Authors:  Tiantian Guo; Denghong Zhang; Yuzhe Zeng; Timothy Y Huang; Huaxi Xu; Yingjun Zhao
Journal:  Mol Neurodegener       Date:  2020-07-16       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.